Heel pain management with Agnikarma

Phase 2

• Conditions: Health Condition 1: M722- Plantar fascial fibromatosis

• Registration Number: CTRI/2019/04/018369
• Lead Sponsor: Dr S P Badole

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. Age:-20 to 60 years

2. Gender:-Both

3. Patients with classical signs and symptoms of plantar fasciitis and giving voluntary informed consent.

Exclusion Criteria

1.Uncontrolled Diabetes(HbA1c > 7.5) and with its complication

2.Pregnancy and lactation

3. Infective foot pathology

4. Fracture

5. Rheumatism, Gout

6. Nerve entrapment syndromes

7. sciatica

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain <br/ ><br> <br/ ><br>Timepoint: Day 4,8,12,16,30,60,90

Secondary Outcome Measures

Name	Time	Method
Agnikarma with Mrutika Shalaka relives pain of plantar fasciitis instantly <br/ ><br> <br/ ><br> <br/ ><br>Secondary OutcomeAgnikarma with Mrutika Shalaka reduces thickness of plantar fascia in the plantar fasciitis and is significantly more effective than the standard modality of Therapeutic Ultrasound <br/ ><br> <br/ ><br>Timepoint: Day 4,8,12,16,30,60,90